Nanobiotix S.A. – NASDAQ:NBTX
Founder-led company
Nanobiotix S.A. stock price today
$6.01
+3.01
+100.33%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Nanobiotix S.A. stock price monthly change
-47.18%
month
Nanobiotix S.A. stock price quarterly change
-47.18%
quarter
Nanobiotix S.A. stock price yearly change
-56.96%
year
Nanobiotix S.A. key metrics
Market Cap | 153.28M |
Enterprise value | 48.35M |
P/E | -10.92 |
EV/Sales | 68.15 |
EV/EBITDA | -4.36 |
Price/Sales | 158.47 |
Price/Book | 4.19 |
PEG ratio | N/A |
EPS | -1.62 |
Revenue | 49.80M |
EBITDA | -40.71M |
Income | -59.55M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -1450.25% |
Oper. margin | -1295.56% |
Gross margin | 100% |
EBIT margin | -1295.56% |
EBITDA margin | -81.74% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNanobiotix S.A. stock price history
Nanobiotix S.A. stock forecast
Nanobiotix S.A. financial statements
| Mar 2023 | 1.64M | -14.04M | -853.29% |
|---|---|---|---|
| Jun 2023 | 1.64M | -28.09M | -1706.59% |
| Sep 2023 | 16.45M | -5.80M | -35.25% |
| Dec 2023 | 30.05M | -11.60M | -38.6% |
| 2025 | 50.85M | -24.72M | -48.62% |
|---|---|---|---|
| 2026 | 64.36M | -6.81M | -10.59% |
| 2027 | 74.54M | -4.46M | -5.98% |
| 2028 | 79.25M | -24.58M | -31.02% |
Analysts Price target
Financials & Ratios estimates
| Mar 2023 | 40407000 | 94.19M | 233.1% |
|---|---|---|---|
| Jun 2023 | 40407000 | 94.19M | 233.11% |
| Sep 2023 | 93897000 | 95.74M | 101.96% |
| Dec 2023 | 93897000 | 95.74M | 101.96% |
| Mar 2023 | -8.63M | -163.5K | -1.06M |
|---|---|---|---|
| Jun 2023 | -17.57M | -327K | -1.83M |
| Sep 2023 | 2.39M | -11K | 24.45M |
| Dec 2023 | -1.87M | -22K | 55.58M |
Nanobiotix S.A. alternative data
| Aug 2023 | 102 |
|---|---|
| Sep 2023 | 102 |
| Oct 2023 | 102 |
| Nov 2023 | 101 |
| Dec 2023 | 101 |
| Jan 2024 | 101 |
| Feb 2024 | 101 |
| Mar 2024 | 101 |
| Apr 2024 | 101 |
| May 2024 | 101 |
| Jun 2024 | 102 |
| Jul 2024 | 102 |
Nanobiotix S.A. other data
0.01%
-0.00%
of NBTX is owned by hedge funds
2.40M
-1.06M
shares is hold by hedge funds
| Quarter | Transcript |
|---|---|
| Q1 2024 22 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Apr 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 27 Sep 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Laurent Levy Ph.D. (1973) Co-Founder, Pres of the Executive Board & Chief Executive Officer | $579,820 |
Ms. Anne-Juliette Hermant M.A. (1974) Chief People Officer & Member of Executive Board | $339,060 |
-
What's the price of Nanobiotix S.A. stock today?
One share of Nanobiotix S.A. stock can currently be purchased for approximately $6.01.
-
When is Nanobiotix S.A.'s next earnings date?
Unfortunately, Nanobiotix S.A.'s (NBTX) next earnings date is currently unknown.
-
Does Nanobiotix S.A. pay dividends?
No, Nanobiotix S.A. does not pay dividends.
-
How much money does Nanobiotix S.A. make?
Nanobiotix S.A. has a market capitalization of 153.28M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 529.36% to 30.06M US dollars.
-
What is Nanobiotix S.A.'s stock symbol?
Nanobiotix S.A. is traded on the NASDAQ under the ticker symbol "NBTX".
-
What is Nanobiotix S.A.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Nanobiotix S.A.?
Shares of Nanobiotix S.A. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Nanobiotix S.A.'s key executives?
Nanobiotix S.A.'s management team includes the following people:
- Mr. Laurent Levy Ph.D. Co-Founder, Pres of the Executive Board & Chief Executive Officer(age: 52, pay: $579,820)
- Ms. Anne-Juliette Hermant M.A. Chief People Officer & Member of Executive Board(age: 51, pay: $339,060)
-
Is Nanobiotix S.A. founder-led company?
Yes, Nanobiotix S.A. is a company led by its founder Mr. Laurent Levy Ph.D..
-
How many employees does Nanobiotix S.A. have?
As Jul 2024, Nanobiotix S.A. employs 102 workers, which is 1% more then previous quarter.
-
When Nanobiotix S.A. went public?
Nanobiotix S.A. is publicly traded company for more then 4 years since IPO on 11 Dec 2020.
-
What is Nanobiotix S.A.'s official website?
The official website for Nanobiotix S.A. is nanobiotix.com.
-
How can i contact Nanobiotix S.A.?
Nanobiotix S.A. can be reached via phone at +33 1 40 26 04 70.
Nanobiotix S.A. company profile:
Nanobiotix S.A.
nanobiotix.comExchange:
NASDAQ
Full time employees:
110
Industry:
Biotechnology
Sector:
Healthcare
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.
60 rue de Wattignies
Paris, 75012
Paris, 75012
CIK: 0001760854
ISIN: US63009J1079
CUSIP: 63009J107
